Glycode

France
Uzerche, Nouvelle-Aquitaine, France, 19140

Company profile

Glycode company profile

Glycode SAS, a biotechnology company, operates in the field of protein glycosylation in France. It provides and licenses GlycodExpress, a yeast based technological platform for the production of recombinant therapeutic glycoproteins for therapeutic purposes, such as antibodies, EPOs, and growth factors, as well as allows humanization of N-glycosylation in Saccharomyces cerevisiae. The company also offers on-demand production and purification services, from the conception and synthesis of optimized expression vectors for protein expression in glycoengineered yeasts to the early steps of production process. Glycode SAS serves biotechnology and pharmaceutical companies. The company was founded in 2004 and is based in Uzerche, France.

Business identity

Phone number
33 5 55 73 77 19
Operating status
Closed
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2004-01-01, Year

Headquarters

Postal code
19140
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$4.3M
Last funding
Series B / $4.3M / 2010-01-18
Last equity funding
Series B / $4.3M
Investors
4
Founders
1

Founders and investors

Founders

Christophe Javaud

Investors

Limousin ParticipationsOctalfaShamSofimac Investment Managers